5,895
Views
27
CrossRef citations to date
0
Altmetric
Editorial

Metabolite profiling in early clinical drug development: current status and future prospects

, , , &
Pages 803-806 | Received 14 Mar 2017, Accepted 04 Jul 2017, Published online: 13 Jul 2017
 

Declaration of interest

The authors are all employees of Idorsia Pharmaceuticals Ltd or hold stock or share options. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Additional information

Funding

This paper is not funded

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.